bucladesine has been researched along with Human T-lymphotropic Virus 1 Infection in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cash, E; Fleischer, B; Rott, O; Tontsch, U | 1 |
Dardik, M; Poteat, HT; Ramstedt, U; Sodroski, JG; Terwilliger, E; Yoon, S | 1 |
Neckers, LM | 1 |
1 review(s) available for bucladesine and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
Regulation of transferrin receptor expression and control of cell growth.
Topics: Bucladesine; Calcium Channels; Cyclic AMP; Diltiazem; Gene Expression Regulation; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interleukin-6; Interphase; Lymphocyte Activation; Lymphocytes; Phorbol Esters; Receptors, Interleukin-2; Receptors, Transferrin; Transferrin; Tumor Cells, Cultured | 1991 |
2 other study(ies) available for bucladesine and Human T-lymphotropic Virus 1 Infection
Article | Year |
---|---|
Interleukin-6 production in "normal" and HTLV-1 tax-expressing brain-specific endothelial cells.
Topics: Animals; Brain; Bucladesine; Cells, Cultured; Endothelium, Vascular; Genes, pX; HTLV-I Infections; Interleukin-6; Mice; Mice, Inbred BALB C; RNA, Messenger; Transfection | 1993 |
Cyclic AMP-mediated growth arrest is associated with increased expression of human T cell leukemia virus type I structural and transforming genes.
Topics: Bucladesine; Caffeine; Cyclic AMP; Gene Expression Regulation, Viral; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Prostaglandins E; Proviruses; Receptors, Interleukin-2; Retroviridae Proteins, Oncogenic; RNA, Viral; T-Lymphocytes; Viral Proteins | 1996 |